For the year ending 2025-12-31, PRCT had -$47,222K decrease in cash & cash equivalents over the period. -$58,341K in free cash flow.
| Cash Flow | 2025-12-31 |
|---|---|
| Net loss | -95,572 |
| Depreciation and amortization | 6,390 |
| Stock-based compensation expense | 47,603 |
| Change in fair value in derivative liability | 0 |
| Non-cash lease adjustment | 508 |
| Provision for credit losses | 219 |
| Inventory write-down | 565 |
| (gain) loss on foreign currency transactions | -157 |
| Accounts receivable, net | 898 |
| Inventory | 14,498 |
| Prepaid expenses and other current assets | 1,102 |
| Other assets | 2,895 |
| Accounts payable | 6,648 |
| Accrued compensation | 1,590 |
| Accrued interest expense | 142 |
| Loan facility liability | -2,000 |
| Deferred revenue | 3,306 |
| Reimbursements for leasehold improvements from operating leases | 0 |
| Other liabilities | 1,868 |
| Net cash used in operating activities | -48,985 |
| Purchases of property and equipment | 9,356 |
| Net cash used in investing activities | -9,356 |
| Proceeds from issuance of common stock under employee stock purchase plan | 6,362 |
| Proceeds from issuance of common stock from the exercise of stock options, net | 4,831 |
| Proceeds from issuance of common stock, net of issuance costs | 0 |
| Net cash provided by financing activities | 11,193 |
| Effect of exchange rates on cash, cash equivalents and restricted cash | -74 |
| Net increase (decrease) in cash, cash equivalents and restricted cash | -47,222 |
| Beginning of the period | 336,763 |
| End of the period | 289,541 |
PROCEPT BioRobotics Corp (PRCT)
PROCEPT BioRobotics Corp (PRCT)